Making Sense of the Bitcoin Cash Split
When Thursday finally arrived, the long-anticipated hard fork of bitcoin cash (BCH) looked less like an all-out war, as some had feared, and more...
Why Most ‘Smart’ Cities Haven’t Embraced Blockchain
There’s a certain appeal to being a "smart city." When nearly everything is connected by internet of things devices, the collected data and technology...
Blockchain’s Impact on Recruiting in the Accounting Industry
With the cryptocurrency market hurtling toward a $1 trillion valuation, major accounting firms have had to reconsider their hiring needs.
Over the past two years,...
Primalbase Brings Blockchain, Tokens to Coworking
Primalbase is offering an alternative to WeWork, Regus and other companies that rent shared workspaces to business professionals by offering a way to do...
Digital Currency Group Leads List of Top 50 Blockchain VCs
Many industries have “best of” lists and rankings that insiders love to peruse. Now venture capitalists focused on blockchain technology have one of their...
ExsulCoin CEO: Blockchain Is Solution for Refugee Communities
Next month, ExsulCoin plans to conduct its initial coin offering. The company mixes blockchain technology and social consciousness, connecting the Rohingya and other refugee groups to...
W. Va. Blockchain Experiment Could Be the Future of U.S. Voting
With the U.S. election process shown to be vulnerable to hacking during the 2016 presidential race, West Virginia could be leading the way to prevent...
Something on the Side: Stratis Offering Sidechains to Businesses
Stratis says it wants to make blockchain easy for your business, which is why it operates a platform to help you develop your own blockchain applications. Now...
Lucidity Wants Blockchain to Make a Better Ad Impression
Each time a digital ad appears on a computer screen counts as one impression. But how can advertisers be sure they’re paying for the correct...
Embleema Tests Blockchain for Patient Health Care Data
As pharmaceuticals become more personalized to individuals’ specific genomes, drug developers must rely on medical data gathered outside clinical trials, known as real world...